Welcome to FMD™

Fountain was established and operated by some of the pioneers in the Chinese CRO market. In addition to the founders, we have assembled the highest quality team that is capable of handing regulatory affairs, clinical operations, safety, project management, data management and statistical analysis. Furthermore, through our internal team and a global network of consultants, we are one of the only local CRO's capable of global standard clinical trial protocol design. In summary, we have been service providers, we have hands-on clinical trial experiences in both China and the US, and client success is our passion. We believe that experience, responsiveness, flexibility and attention to details are the cornerstones of successful product development.

Overview

Fountain Medical Development Corp. is a contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services for multinational clients conducting clinical research in China. The management team of Fountain has decades of combined experience working with the world's leading CRO's and drug developers. In the Chinese CRO market, we fill the void of a service provider that balances high quality with moderate cost. Our extensive global experience in multiple therapeutic areas is unmatched by other local CRO's, and our lower operational cost allows us to pass significant savings on to our clients.
Latest News
A grateful letter from CDE

“It is a great honor that our president & CEO Dr Zhang Dan has been invited as consultant by CDE. Per invitation he gave an important presentation in CDE seminar of innovative drug R & D, Shanghai 2009. Hereby CDE express high appreciation of his work with the thanking letter. ”

Dr. Dan Zhang was interviewed by PharmaAsia news on the new drug safety regulation issued by SFDA.

"The new version has expanded significantly" It clearly spells out the reporting timeline for death case, as well as AE and SAEs.  It also clearly identifies the role/responsibilities of city level, provincial level and SFDA in handling AE and SAE cases. ¡°   For detail information on the new regulation and its impact on conducting clinical trials in China.  Please contact FMD for one-on-one consultation.

USA
Joanne Jiang, Ph.D., MBA
Fountain Medical Development
Tel: 732-447-6898
Email:joanne.jiang@fountain-med.com

BEIJING(China)
Phone: 86-10-8440-6940
SHANGHAI(China)
Phone:86-21-51088628
TIANJIN(China)
Phone: 86-22-25327420
Welcome to FMD